These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1067 related articles for article (PubMed ID: 9512716)
1. Solution structure of the C-terminal SH2 domain of the p85 alpha regulatory subunit of phosphoinositide 3-kinase. Siegal G; Davis B; Kristensen SM; Sankar A; Linacre J; Stein RC; Panayotou G; Waterfield MD; Driscoll PC J Mol Biol; 1998 Feb; 276(2):461-78. PubMed ID: 9512716 [TBL] [Abstract][Full Text] [Related]
2. Backbone dynamics of the C-terminal SH2 domain of the p85alpha subunit of phosphoinositide 3-kinase: effect of phosphotyrosine-peptide binding and characterization of slow conformational exchange processes. Kristensen SM; Siegal G; Sankar A; Driscoll PC J Mol Biol; 2000 Jun; 299(3):771-88. PubMed ID: 10835283 [TBL] [Abstract][Full Text] [Related]
3. The three-dimensional solution structure of the SH2 domain from p55blk kinase. Metzler WJ; Leiting B; Pryor K; Mueller L; Farmer BT Biochemistry; 1996 May; 35(20):6201-11. PubMed ID: 8639560 [TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate. Hoedemaeker FJ; Siegal G; Roe SM; Driscoll PC; Abrahams JP J Mol Biol; 1999 Oct; 292(4):763-70. PubMed ID: 10525402 [TBL] [Abstract][Full Text] [Related]
5. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck. Eck MJ; Shoelson SE; Harrison SC Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435 [TBL] [Abstract][Full Text] [Related]
6. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins. Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362 [TBL] [Abstract][Full Text] [Related]
7. Two phosphorylation-independent sites on the p85 SH2 domains bind A-Raf kinase. Fang Y; Johnson LM; Mahon ES; Anderson DH Biochem Biophys Res Commun; 2002 Feb; 290(4):1267-74. PubMed ID: 11812000 [TBL] [Abstract][Full Text] [Related]
8. Dissection of the energetic coupling across the Src SH2 domain-tyrosyl phosphopeptide interface. Lubman OY; Waksman G J Mol Biol; 2002 Feb; 316(2):291-304. PubMed ID: 11851339 [TBL] [Abstract][Full Text] [Related]
9. Alternative modes of binding of proteins with tandem SH2 domains. O'Brien R; Rugman P; Renzoni D; Layton M; Handa R; Hilyard K; Waterfield MD; Driscoll PC; Ladbury JE Protein Sci; 2000 Mar; 9(3):570-9. PubMed ID: 10752619 [TBL] [Abstract][Full Text] [Related]
10. Correlation between dynamics and high affinity binding in an SH2 domain interaction. Kay LE; Muhandiram DR; Farrow NA; Aubin Y; Forman-Kay JD Biochemistry; 1996 Jan; 35(2):361-8. PubMed ID: 8555205 [TBL] [Abstract][Full Text] [Related]
11. Nuclear magnetic resonance solution structure of the growth factor receptor-bound protein 2 Src homology 2 domain. Thornton KH; Mueller WT; McConnell P; Zhu G; Saltiel AR; Thanabal V Biochemistry; 1996 Sep; 35(36):11852-64. PubMed ID: 8794768 [TBL] [Abstract][Full Text] [Related]
12. Interaction of the insulin receptor beta-subunit with phosphatidylinositol 3-kinase in bovine ROS. Rajala RV; Anderson RE Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3110-7. PubMed ID: 11726610 [TBL] [Abstract][Full Text] [Related]
13. Mutational investigation of the specificity determining region of the Src SH2 domain. Bradshaw JM; Mitaxov V; Waksman G J Mol Biol; 2000 Jun; 299(2):521-35. PubMed ID: 10860756 [TBL] [Abstract][Full Text] [Related]
14. Investigation of phosphotyrosine recognition by the SH2 domain of the Src kinase. Bradshaw JM; Mitaxov V; Waksman G J Mol Biol; 1999 Nov; 293(4):971-85. PubMed ID: 10543978 [TBL] [Abstract][Full Text] [Related]
15. Structure of an SH2 domain of the p85 alpha subunit of phosphatidylinositol-3-OH kinase. Booker GW; Breeze AL; Downing AK; Panayotou G; Gout I; Waterfield MD; Campbell ID Nature; 1992 Aug; 358(6388):684-7. PubMed ID: 1323062 [TBL] [Abstract][Full Text] [Related]
16. Specificity determinants of a novel Nck interaction with the juxtamembrane domain of the epidermal growth factor receptor. Hake MJ; Choowongkomon K; Kostenko O; Carlin CR; Sönnichsen FD Biochemistry; 2008 Mar; 47(10):3096-108. PubMed ID: 18269246 [TBL] [Abstract][Full Text] [Related]
17. Solution structure of the SH2 domain of Grb2 complexed with the Shc-derived phosphotyrosine-containing peptide. Ogura K; Tsuchiya S; Terasawa H; Yuzawa S; Hatanaka H; Mandiyan V; Schlessinger J; Inagaki F J Mol Biol; 1999 Jun; 289(3):439-45. PubMed ID: 10356320 [TBL] [Abstract][Full Text] [Related]
18. Identification of residues in the beta platelet-derived growth factor receptor that confer specificity for binding to phospholipase C-gamma 1. Larose L; Gish G; Shoelson S; Pawson T Oncogene; 1993 Sep; 8(9):2493-9. PubMed ID: 7689724 [TBL] [Abstract][Full Text] [Related]
19. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains. Chalupny NJ; Aruffo A; Esselstyn JM; Chan PY; Bajorath J; Blake J; Gilliland LK; Ledbetter JA; Tepper MA Eur J Immunol; 1995 Oct; 25(10):2978-84. PubMed ID: 7589101 [TBL] [Abstract][Full Text] [Related]
20. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin. Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]